@Domesticgod,
My opinion has changed since last week.
The FDA is not requiring the trial be done in adults. I believe the Company still has the choice to run a trial in adults or children. The Company has chosen adults, not because of an FDA requirement, but because some consider it unethical to run a placebo-controlled trial in children. I'll let the ethicists debate that point. The whole foundation of RCT's is that it's ethical to run a trial when a medication remains "unproven".... because that's the only way to prove it. Note especially that proof of a reduction in mortality in an RCT requires.... higher mortality in the control arm. How else can you prove there's been a reduction?
CEO Itescu needs to go, page-42
-
- There are more pages in this discussion • 868 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
93.5¢ |
Change
0.020(2.19%) |
Mkt cap ! $1.067B | |||
| Open | High | Low | Value | Volume |
| 92.0¢ | 94.5¢ | 92.0¢ | $1.622M | 1.742M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 64563 | 93.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 94.0¢ | 204239 | 3 |
View Market Depth
| Last trade - 16.10pm 11/09/2024 (20 minute delay) ? |
| MSB (ASX) Chart |